- Home
- ECOR vs SYTA Comparison
ECOR vs SYTA Comparison
Compare ECOR & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- SYTA
- Stock Information
- Founded
- ECOR 2005
- SYTA N/A
- Country
- ECOR United States
- SYTA Canada
- Employees
- ECOR N/A
- SYTA N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SYTA Telecommunications Equipment
- Sector
- ECOR Health Care
- SYTA Telecommunications
- Exchange
- ECOR Nasdaq
- SYTA Nasdaq
- Market Cap
- ECOR 39.7M
- SYTA 38.2M
- IPO Year
- ECOR 2018
- SYTA 2020
- Fundamental
- Price
- ECOR $5.37
- SYTA $3.06
- Analyst Decision
- ECOR Strong Buy
- SYTA
- Analyst Count
- ECOR 2
- SYTA 0
- Target Price
- ECOR $25.50
- SYTA N/A
- AVG Volume (30 Days)
- ECOR 118.5K
- SYTA 787.8K
- Earning Date
- ECOR 08-06-2025
- SYTA 08-14-2025
- Dividend Yield
- ECOR N/A
- SYTA N/A
- EPS Growth
- ECOR N/A
- SYTA N/A
- EPS
- ECOR N/A
- SYTA N/A
- Revenue
- ECOR $27,700,000.00
- SYTA $11,883,835.00
- Revenue This Year
- ECOR $23.21
- SYTA $18.41
- Revenue Next Year
- ECOR $44.10
- SYTA N/A
- P/E Ratio
- ECOR N/A
- SYTA N/A
- Revenue Growth
- ECOR 30.16
- SYTA 49.13
- 52 Week Low
- ECOR $4.16
- SYTA $0.93
- 52 Week High
- ECOR $19.49
- SYTA $29.20
- Technical
- Relative Strength Index (RSI)
- ECOR 42.75
- SYTA 41.34
- Support Level
- ECOR $4.16
- SYTA $3.23
- Resistance Level
- ECOR $5.74
- SYTA $3.85
- Average True Range (ATR)
- ECOR 0.53
- SYTA 0.31
- MACD
- ECOR -0.16
- SYTA -0.07
- Stochastic Oscillator
- ECOR 37.19
- SYTA 17.86
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.